Management of Anemia in Lower-Risk Myelodysplastic Syndromes/Neoplasms With Novel Agents

Fieke W. Hoff, Stephen S. Chung, Amer M. Zeidan, Yazan F. Madanat

Open source

DOI
10.1200/op-24-00910
Published
2026-06
Container
JCO Oncology Practice
Publisher
American Society of Clinical Oncology (ASCO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/op-24-00910,
  title = {Management of Anemia in Lower-Risk Myelodysplastic Syndromes/Neoplasms With Novel Agents},
  author = {Fieke W. Hoff and Stephen S. Chung and Amer M. Zeidan and Yazan F. Madanat},
  year = {2026},
  journal = {JCO Oncology Practice},
  doi = {10.1200/op-24-00910},
  url = {https://doi.org/10.1200/op-24-00910}
}

RIS

TY  - JOUR
TI  - Management of Anemia in Lower-Risk Myelodysplastic Syndromes/Neoplasms With Novel Agents
AU  - Fieke W. Hoff
AU  - Stephen S. Chung
AU  - Amer M. Zeidan
AU  - Yazan F. Madanat
PY  - 2026
JO  - JCO Oncology Practice
DO  - 10.1200/op-24-00910
UR  - https://doi.org/10.1200/op-24-00910
ER  - 

APA

Hoff, F. W., Chung, S. S., Zeidan, A. M., & Madanat, Y. F. (2026). Management of Anemia in Lower-Risk Myelodysplastic Syndromes/Neoplasms With Novel Agents. JCO Oncology Practice. https://doi.org/10.1200/op-24-00910

Source records